IX Biopharma Company Announcements (42C)

SGX Google Yahoo News TradingView

IX BIOPHARMA LTD. (42C) SGD 0.125 +2.40% +0.00

Portfolio Watchlist

All Financial Buy Back Insider Trading

2017-11-08

General Announcement::Establishment of A Risk Management Committee

2017-11-08

Financial Statements and Related Announcement::First Quarter Results

2017-10-24

General Announcement::Responses to SIAS' Questions on iX Biopharma's Annual Report FY2017

2017-10-24

REPL::Extraordinary/ Special General Meeting::Voluntary

2017-10-24

REPL::Annual General Meeting::Voluntary

2017-10-23

General Announcement::iX Biopharma Secures European Patent for WaferiX Drug Delivery Technology

2017-09-27

Extraordinary/ Special General Meeting::Voluntary

2017-09-27

Annual Reports and Related Documents::

2017-09-27

Annual General Meeting::Voluntary

2017-08-23

Financial Statements and Related Announcement::Full Yearly Results

2017-05-15

General Announcement::iX Biopharma Launches New Supplements Business Arm

2017-05-14

General Announcement::iX Biopharma Reports Positive Results from Pharmacokinetic Study of BnoX

2017-05-11

Financial Statements and Related Announcement::Third Quarter Results

2017-02-10

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interest in Securities

2017-02-08

Financial Statements and Related Announcement::Second Quarter and/ or Half Yearly Results

2016-12-29

Employee Stock Option/ Share Scheme::ISSUE AND ALLOTMENT OF NEW SHARES PURSUANT TO iX PERFORMANCE SHARE PLAN

2016-11-21

General Announcement::iX Biopharma Secures South African Patent for Waferix Drug Delivery Technology

2016-11-15

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interest in Securities

2016-11-11

Financial Statements and Related Announcement::First Quarter Results

2016-10-31

General Announcement::iX Biopharma Secures Canadian Patent for WaferiX Drug Delivery Technology

2016-10-25

General Announcement::Responses to SIAS' Questions on iX Biopharma's Annual Report FY2016

2016-10-25

REPL::Annual General Meeting::Voluntary

2016-10-05

Annual Reports and Related Documents::

2016-10-05

Annual General Meeting::Voluntary

2016-10-04

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification in Respect of Changes in Interest of a Director - Eddy Lee Yip Hang

2016-09-30

Employee Stock Option/ Share Scheme::GRANT OF SHARE AWARDS PURSUANT TO iX PERFORMANCE SHARE PLAN

2016-09-13

General Announcement::iX Biopharma Announces Positive Results from Pivotal Study of Erectile Dysfunction Drug

2016-08-25

Financial Statements and Related Announcement::Full Yearly Results

2016-08-17

General Announcement::iX Biopharma Announces Development of Supplement for Jet Lag

2016-08-10

General Announcement::iX Biopharma is Developing its Next Drug in Pain Management

2016-07-22

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interest in Securities

2016-07-22

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interest in Securities

2016-07-22

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interest in Securities

2016-07-22

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interest in Securities

2016-07-22

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interest in Securities

2016-07-21

REPL::Rights::Voluntary

2016-07-18

General Announcement::Results of the Rights Issue

2016-07-04

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interest in Securities

2016-07-01

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interest in Securities

2016-07-01

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interest in Securities

2016-07-01

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interest in Securities

2016-07-01

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interest in Securities

2016-06-30

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interest in Securities

2016-06-27

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities

2016-06-24

General Announcement::REPL::Rights::Voluntary

2016-06-24

REPL::Rights::Voluntary

2016-06-15

REPL::Rights::Voluntary

2016-06-14

REPL::Rights::Voluntary

2016-06-09

General Announcement::iX Biopharma Secures South Korea Patent for Waferix

2016-06-02

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities

© 2025 Dividends.sg / More Countries